2C-TFM
| Clinical data | |
|---|---|
| Other names | 2C-CF3; 2,5-Dimethoxy-4-trifluoromethylphenethylamine; 4-Trifluoromethyl-2,5-dimethoxyphenethylamine |
| Routes of administration | Oral |
| Drug class | Serotonin 5-HT2 receptor agonist; Serotonergic psychedelic; Hallucinogen |
| Pharmacokinetic data | |
| Duration of action | ≥5–10 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H14F3NO2 |
| Molar mass | 249.233 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 260 °C (500 °F) (hydrochloride) |
| |
| |
| (verify) | |
2C-TFM, also known as 4-trifluoromethyl-2,5-dimethoxyphenethylamine, is a serotonin 5-HT2 receptor agonist and psychedelic drug of the phenethylamine and 2C families. It has also been called 2C-CF3, a name derived from the para-trifluoromethyl group it contains. The drug was first synthesized in the laboratory of David E. Nichols. Later, it was tried humans and its psychedelic effects were confirmed. 2C-TFM is the most potent psychedelic of the 2C psychedelics, with an active dosage of 3 to 6 mg orally.